2009
DOI: 10.4070/kcj.2009.39.12.545
|View full text |Cite
|
Sign up to set email alerts
|

Eosinophilic Endomyocarditis Combined With Pericardial and Pleural Effusion

Abstract: Eosinophilic endomyocarditis is a manifestation of hypereosinophilic syndrome, characterized by prolonged (>6 months), unexplained peripheral blood eosinophilia (>1,500 cells/mm3) with end-organ damage in unknown causes. We report a case of a 42-year-old patient who developed eosinophilic endomyocarditis following upper respiratory tract symptoms for 2 months. Additionally, endomyocarditis was combined with massive pleural effusion and pericardial effusion, which have not been reported in Korea.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…These mechanisms include hypersensitivity, allergic reaction, direct toxic effect, increased oxygen free radical production, suppression of the antioxidant defense mechanism, and chemical-induced inflammation. 4) 5) Approximately 30 drugs are believed to cause pleural disease, and development of pleural fluid eosinophilia has been reported in association with therapy with the following drugs: dantrolene, nitrofurantoin, fluoxetine, warfarin, gliclazide, propylthiouracil, isotrentinoin, mesalamine, bromocriptine, valproic acid, tinazidine, and antibiotics such as penicillin, ceftriaxone, and streptomycin. 2) 3) The presence of eosinophilia in pleural fluid may provide a clinical clue to the presence of drug-induced pleural disease but its presence or absence is not specific.…”
Section: Discussionmentioning
confidence: 99%
“…These mechanisms include hypersensitivity, allergic reaction, direct toxic effect, increased oxygen free radical production, suppression of the antioxidant defense mechanism, and chemical-induced inflammation. 4) 5) Approximately 30 drugs are believed to cause pleural disease, and development of pleural fluid eosinophilia has been reported in association with therapy with the following drugs: dantrolene, nitrofurantoin, fluoxetine, warfarin, gliclazide, propylthiouracil, isotrentinoin, mesalamine, bromocriptine, valproic acid, tinazidine, and antibiotics such as penicillin, ceftriaxone, and streptomycin. 2) 3) The presence of eosinophilia in pleural fluid may provide a clinical clue to the presence of drug-induced pleural disease but its presence or absence is not specific.…”
Section: Discussionmentioning
confidence: 99%
“…An eosinophilic pleural effusion is the most common reported type, whereas an eosinophilic pericardial effusion and ascites are seldom described . An eosinophilic pericardial effusion is clinically more important because it is a sign of a life‐threatening cardiac damage in the form of eosinophilic myocarditis with secondary eosinophilic pericarditis . Differential diagnoses include parasitic infestations, drugs, hypereosinophilic syndrome, Churg–Strauss syndrome, and restrictive cardiomyopathy .…”
mentioning
confidence: 99%
“…An eosinophilic pericardial effusion is clinically more important because it is a sign of a life‐threatening cardiac damage in the form of eosinophilic myocarditis with secondary eosinophilic pericarditis . Differential diagnoses include parasitic infestations, drugs, hypereosinophilic syndrome, Churg–Strauss syndrome, and restrictive cardiomyopathy . HES is a rare leucoproliferative disorder of unknown aetiology with infrequent pericardial involvement.…”
mentioning
confidence: 99%